Cyclerion Therapeutics (CYCN) Q2 2025 Earnings

Screener

Reported August 5, 2025 · Before market open

Revenue$93.0K

EPS-$0.11

Next report

Nov 11, 2026 (in 2 months)

Revenue estimate$900.0K

EPS estimate-$6.00

Versus estimates

Revenue

Q4 2025$100.0KIn line Q1 2024$100.0KIn line Q3 2025$875.0K

Q2 2025$93.0K

Diluted EPS

Q2 2026-$0.41Beat by $6.69 Q1 2026-$0.76Beat by $16.44 Q4 2025-$0.19Beat by $0.19 Q1 2024-$0.38In line Q3 2025-$0.30

Q2 2025-$0.11

FAQ

When did Cyclerion Therapeutics report Q2 2025 earnings?: Cyclerion Therapeutics (CYCN) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Cyclerion Therapeutics's Q2 2025 revenue and EPS?: Cyclerion Therapeutics reported revenue of $93.0K and eps of $-0.11 for Q2 2025.
Where can I find Cyclerion Therapeutics's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0000950170-25-103123) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk